146 related articles for article (PubMed ID: 14966091)
1. Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker.
Scorilas A; Borgoño CA; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP
J Clin Oncol; 2004 Feb; 22(4):678-85. PubMed ID: 14966091
[TBL] [Abstract][Full Text] [Related]
2. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
Borgoño CA; Kishi T; Scorilas A; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP
Clin Cancer Res; 2006 Mar; 12(5):1487-93. PubMed ID: 16533772
[TBL] [Abstract][Full Text] [Related]
3. Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients.
Diamandis EP; Borgoño CA; Scorilas A; Harbeck N; Dorn J; Schmitt M
Clin Biochem; 2004 Sep; 37(9):823-9. PubMed ID: 15329323
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Luo LY; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais IA; Howarth DJ; Diamandis EP
Clin Cancer Res; 2001 Aug; 7(8):2372-9. PubMed ID: 11489815
[TBL] [Abstract][Full Text] [Related]
5. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
[TBL] [Abstract][Full Text] [Related]
6. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
[TBL] [Abstract][Full Text] [Related]
7. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Luo LY; Katsaros D; Scorilas A; Fracchioli S; Bellino R; van Gramberen M; de Bruijn H; Henrik A; Stenman UH; Massobrio M; van der Zee AG; Vergote I; Diamandis EP
Cancer Res; 2003 Feb; 63(4):807-11. PubMed ID: 12591730
[TBL] [Abstract][Full Text] [Related]
8. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.
Yousef GM; Scorilas A; Katsaros D; Fracchioli S; Iskander L; Borgono C; Rigault de la Longrais IA; Puopolo M; Massobrio M; Diamandis EP
J Clin Oncol; 2003 Aug; 21(16):3119-26. PubMed ID: 12915603
[TBL] [Abstract][Full Text] [Related]
10. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP
Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385
[TBL] [Abstract][Full Text] [Related]
11. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
[TBL] [Abstract][Full Text] [Related]
12. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis.
Diamandis EP; Borgoño CA; Scorilas A; Yousef GM; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M
Tumour Biol; 2003; 24(6):299-309. PubMed ID: 15004490
[TBL] [Abstract][Full Text] [Related]
13. A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy.
Zheng Y; Katsaros D; Shan SJ; de la Longrais IR; Porpiglia M; Scorilas A; Kim NW; Wolfert RL; Simon I; Li L; Feng Z; Diamandis EP
Clin Cancer Res; 2007 Dec; 13(23):6984-92. PubMed ID: 18056174
[TBL] [Abstract][Full Text] [Related]
14. Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.
Dorn J; Schmitt M; Kates R; Schmalfeldt B; Kiechle M; Scorilas A; Diamandis EP; Harbeck N
Clin Cancer Res; 2007 Mar; 13(6):1742-8. PubMed ID: 17363527
[TBL] [Abstract][Full Text] [Related]
15. Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients.
Scorilas A; Diamandis EP; Levesque MA; Papanastasiou-Diamandi A; Khosravi MJ; Giai M; Ponzone R; Roagna R; Sismondi P; López-Otin C
Clin Cancer Res; 1999 Jul; 5(7):1778-85. PubMed ID: 10430082
[TBL] [Abstract][Full Text] [Related]
16. Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.
Shan SJ; Scorilas A; Katsaros D; Rigault de la Longrais I; Massobrio M; Diamandis EP
Clin Chem; 2006 Oct; 52(10):1879-86. PubMed ID: 16916986
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.
Yu H; Giai M; Diamandis EP; Katsaros D; Sutherland DJ; Levesque MA; Roagna R; Ponzone R; Sismondi P
Cancer Res; 1995 May; 55(10):2104-10. PubMed ID: 7538047
[TBL] [Abstract][Full Text] [Related]
18. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.
Borgoño CA; Fracchioli S; Yousef GM; Rigault de la Longrais IA; Luo LY; Soosaipillai A; Puopolo M; Grass L; Scorilas A; Diamandis EP; Katsaros D
Int J Cancer; 2003 Sep; 106(4):605-610. PubMed ID: 12845660
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer.
Leoutsakou T; Talieri M; Scorilas A
Biochem Biophys Res Commun; 2006 Jun; 344(2):667-74. PubMed ID: 16631123
[TBL] [Abstract][Full Text] [Related]
20. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]